Nearly 250 insurance decision makers share intel on GenAI strategy, sentiment and innovation
, /PRNewswire/ — Will generative AI prove itself a bane or boon to the insurance industry? A new study exploring the use of generative AI in insurance suggests that 9 in 10 insurers plan to invest in GenAI in the next year. The enthusiasm is palpable – but survey data also shows that the ethical and regulatory implications of innovation continue to vex many insurers, even as analytic ingenuity promises to help the sector address its biggest challenges.
“Insurance is a notoriously slow-moving industry, but insurers are proving to be GenAI trailblazers.”
The study, Your journey to a GenAI future: An insurer’s strategic path to success, comes from a global multi-industry survey by SAS, a data and AI company serving 47 of the world’s 50 largest global insurers, and Coleman Parks Research Ltd. Its findings offer an insider’s look at how insurance …